HILLHOUSE INVESTMENT MANAGEMENT, LTD. sold 12.4% of their position (555.55K shares) of ARRIVENT BIOPHARMA, INC. on the open market
Open‑market sale worth $12.98M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2026ACC: 0000902664-26-000675
10% Owner
Since Dec 2025
-555.55K
Net shares
Net seller
$12.98M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
555.55K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−555.55K
Price / share
$23.37
Trade value
$12.98M
% of position
12.4%
12/10/2025
4.48M→3.93M
Total
Net shares
−555.55K
Net value
-$12.98M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/10/2025 | S · Sale | −555.55K | $23.37 | $12.98M | 12.4% | 4.48M | 3.93M |
| Total | −555.55K | -$12.98M | ||||||
Derivative Transactions0
No derivative transactions reported